Nitrilotriacetic Acid

Nitrilotriacetic Acid

SCHEMBL4149067

CC(C)(O)CON1C(C)(C)CC(O)CC1(C)C.CC(C)(O)CON1C(C)(C)CC(O)CC1(C)C.NCc1ccccc1.O=C(O)CN(CC(=O)O)CC(=O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 1/20 0.38
TSHR P16473 3/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
CHRM2 P08172 3/20 0.32
CHRM1 P11229 3/20 0.32
CHRM3 P20309 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
RORC P51449 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitrilotriacetic Acid SCHEMBL3801112 0.87
Edetic Acid SCHEMBL3799764 0.82 TDP1 (0.36) TSHRKDM4ECHRM2
Edetic Acid SCHEMBL3796431 0.82 TDP1 (0.36) TSHRKDM4ECHRM2
Pentetic Acid SCHEMBL3797811 0.81 TDP1 (0.38) TSHRKDM4ECHRM2
Pentetic Acid SCHEMBL4158519 0.81 TDP1 (0.38) TSHRKDM4ECHRM2
Pentetic Acid SCHEMBL3798491 0.81 TDP1 (0.38) TSHRKDM4ECHRM2
Edetic Acid SCHEMBL4169915 0.76 KDM4E (0.31) KDM4EMAPTSMN1; SMN2
SCHEMBL39209 0.74
Nitrilotriacetic Acid SCHEMBL3801359 0.73 MEN1 (0.35) KMT2AMEN1
Nitrilotriacetic Acid SCHEMBL3865107 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216596-B2 4-Hydroxy-1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidine, citric acid and a body care product; hindered amine salt compounds provide outstanding protection against light-induced fading BASF SE (DE) 2012-07-10 US claimed
EP-1893169-A2 STABILIZED BODY CARE PRODUCTS, HOUSEHOLD PRODUCTS, TEXTILES AND FABRICS CONTAINING STERICALLY HINDERED AMINE SALT COMPOUND Ciba Specialty Chemicals Holding Inc. (CH) 2008-03-05 EP claimed
US-20060262149-A1 Ink jet ink and recording material WOOD MERVIN G 2006-11-23 US claimed
US-20060264345-A1 Stabilized body care products, household products, textiles and fabrics BASF SE (DE) 2006-11-23 US claimed
WO-2006122889-A2 STABILIZED BODY CARE PRODUCTS, HOUSEHOLD PRODUCTS, TEXTILES AND FABRICS CONTAINING STERICALLY HINDERED AMINE SALT COMPOUNDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-11-23 WO claimed
WO-2006122888-A1 INK JET INK AND RECORDING MATERIAL CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-11-23 WO claimed
EP-2207522-B1 PERSONAL CARE AND HOUSEHOLD PRODUCT COMPOSITIONS COMPRISING SPECIFIC SULFUR CONTAINING STABILISER COMPOUNDS BASF SE (DE) 2019-11-06 EP disclosed
US-8216596-B2 4-Hydroxy-1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidine, citric acid and a body care product; hindered amine salt compounds provide outstanding protection against light-induced fading BASF SE (DE) 2012-07-10 US disclosed
US-20090092561-A1 Body-care and household products and compositions comprising specific sulfur-containing compounds BASF SE (DE) 2009-04-09 US disclosed
US-20060262149-A1 Ink jet ink and recording material WOOD MERVIN G 2006-11-23 US disclosed
US-20060264345-A1 Stabilized body care products, household products, textiles and fabrics BASF SE (DE) 2006-11-23 US disclosed
WO-2006122888-A1 INK JET INK AND RECORDING MATERIAL CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264345-A1 Stabilized body care products, household products, textiles and fabrics DSC1, CUTA, DSG1 CYP3A4 4303/4885CYP2D6 3399/4885TSHR 1283/4885
US-20090092561-A1 Body-care and household products and compositions comprising specific sulfur-containing compounds DSC1, SCLY, DSG1 CYP3A4 3771/4885CYP2D6 2511/4885TSHR 2447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.